U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 3.4% during the second quarter, HoldingsChannel reports. The fund owned 157,052 shares of the company’s stock after acquiring an additional 5,111 shares during the quarter. Bank of New York Mellon Corp’s holdings in U.S. Physical Therapy were worth $14,515,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Albert D Mason Inc. raised its stake in shares of U.S. Physical Therapy by 1.1% during the 1st quarter. Albert D Mason Inc. now owns 10,489 shares of the company’s stock worth $1,184,000 after buying an additional 111 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in U.S. Physical Therapy by 1.0% in the first quarter. Conestoga Capital Advisors LLC now owns 15,075 shares of the company’s stock worth $1,702,000 after acquiring an additional 145 shares in the last quarter. Texas Permanent School Fund Corp lifted its holdings in U.S. Physical Therapy by 1.3% in the first quarter. Texas Permanent School Fund Corp now owns 13,116 shares of the company’s stock valued at $1,480,000 after acquiring an additional 170 shares during the period. First Horizon Advisors Inc. boosted its position in shares of U.S. Physical Therapy by 18.6% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after purchasing an additional 186 shares in the last quarter. Finally, Louisiana State Employees Retirement System grew its stake in shares of U.S. Physical Therapy by 2.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $702,000 after purchasing an additional 200 shares during the period.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on USPH. StockNews.com upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating for the company in a research report on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus price target of $112.50.

U.S. Physical Therapy Trading Down 2.6 %

NYSE:USPH opened at $84.56 on Friday. U.S. Physical Therapy, Inc. has a 52-week low of $78.08 and a 52-week high of $113.63. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28. The stock has a fifty day simple moving average of $90.29 and a 200-day simple moving average of $98.37. The company has a market capitalization of $1.28 billion, a PE ratio of 68.75, a price-to-earnings-growth ratio of 4.25 and a beta of 1.39.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.76 EPS. On average, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.51 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Friday, August 23rd will be issued a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 2.08%. The ex-dividend date of this dividend is Friday, August 23rd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 143.09%.

Insiders Place Their Bets

In related news, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction dated Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the completion of the sale, the chief operating officer now directly owns 7,038 shares of the company’s stock, valued at approximately $580,635. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was acquired at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. The disclosure for this purchase can be found here. 1.70% of the stock is currently owned by company insiders.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.